Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 144Radiotherapy 71Fluorouracil 50Radiotherapy, Intensity-Modulated 45Docetaxel 39Gemcitabine 38Cetuximab 38Carboplatin 31pembrolizumab 25Capecitabine 22Drug Therapy 17toripalimab 14Paclitaxel 14camrelizumab 10Surgical Procedures, Operative 10Nivolumab 10Chemoradiotherapy 10nimotuzumab 9Radiation 9Neoadjuvant Therapy 8Methotrexate 8Magnetic Resonance Spectroscopy 8Chemotherapy, Adjuvant 8nedaplatin 7Thyrotropin Alfa 7Platinum 7tislelizumab 6spartalizumab 6Standard of Care 6Specimen Handling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × endostar protein × Head & Neck × Clear all
NCT02907710 2016-09-20

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

First Affiliated Hospital of Guangxi Medical University

Phase 3 Unknown
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡